[ACRX] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
08-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 24.04%
YoY- -2.10%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 377 818 343 740 1,487 2,659 3,109 -75.46%
PBT -12,458 -10,539 -11,592 -10,588 -13,013 -13,057 -15,551 -13.73%
Tax -2,601 2 136 -703 -3,233 2 -2,704 -2.55%
NP -12,458 -10,541 -11,592 -9,885 -13,013 -13,059 -15,551 -13.73%
Tax Rate - - - - - - - -
Total Cost 12,835 11,359 11,935 10,625 14,500 15,718 18,660 -22.06%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin -3,304.51 -1,288.63 -3,379.59 -1,335.81 -875.12 -491.12 -500.19 251.68%
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -4.15 -4.07 -4.55 -3.88 -5.61 -5.76 -6.86 -28.44%
EPS Diluted -4.15 -4.07 -4.55 -3.88 -5.61 -5.76 -6.86 -28.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.